Last updated on May 2017

A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating The Efficacy, Saftey, And Pharmacokinetics Of SAGE-547 Injection In The Treatment Of Adult Female Subjects with Severe Postpartum Depression And Adult female Subjects With Moderate Postpartum Depression.


Brief description of study

A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating The Efficacy, Saftey, And Pharmacokinetics Of SAGE-547 Injection In The Treatment Of Adult Female Subjects with Severe Postpartum Depression And Adult female Subjects With Moderate Postpartum Depression.

Detailed Study Description

The purpose of this study is to test an investigational drug called SAGE-547 (Allopregnolone) to determine if it is safe and has any effect on moderate and/or severe postpartum depression. An investigational drug is one that is not approved by the United States Food and Drug Administration (FDA).

Clinical Study Identifier: TX149850

Find a site near you

Start Over

Cypress Medical Research Center

9300 E. 29th St. North, Suite 104 Wichita, KS USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.